Read our news

and download our White paper now!

As the leading global event for the pharmaceutical industry, CPHI Milan brought together key stakeholders from across the sector to foster connections and innovation.

As a key event for regenerative medicine and biotech innovation, the MAIS Congress in Marbella brought together leading professionals to explore the latest advancements in the field. A unique opportunity to share with the medical aesthetic community our biopolymers platform.

We are excited to announce that the HTL Biotechnology team will be attending CPHI Milan and on this occasion, we will be launching our White Paper to celebrate 90 years of discovery of Hyaluronic Acid!

We are proud to announce that HTL Biotechnology has recently received Halal certification for two of our key products: DNA and HANa. Discover our press release.

CPHI China is one of Asia’s leading Pharma events for trading and networking with 3,500+ exhibitors and 90,000+ professionals from the pharmaceutical industry,

At HTL Biotechnology, we believe in going beyond together to achieve the highest quality standards.

On the occasion of the first National Bioproduction and Biomedicine Day, which took place on the last 5th july, we were very proud to welcome a TVR journalist in our Javené site for an exclusive report.

We are delighted to announce that HTL Biotechnology has once again been awarded the EcoVadis Gold 2024 label for its Corporate Social Responsibility (CSR) performance!

BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Diseases to the Clinical stage.

HTL Biotechnology strengthens its position as a global leader in the production and development of pharmaceutical-grade biopolymers by acquiring the beauty and biomedical division of American company Modern Meadow (Nutley, NJ). Notably, this acquisition includes Modern Meadow’s platform of recombinant proteins, with the most advanced product being human recombinant collagen type III (rhCOL3).